Plain-English translation of NCT05536141 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new medication called to see if it is safe and how well it works for people with advanced kidney cancer or other solid tumors. In the first part of the study, researchers will test by itself at different doses. In the second part, they will test this medication either alone or combined with other cancer drugs that doctors already use.
Kidney cancer and other solid tumors are difficult to treat, and many patients need new treatment options. This trial aims to find out if this medication could help patients whose current treatments are no longer working or who have limited other options.
You likely qualify if…
You likely don't qualify if…
Participants will take the medication by mouth, either once or twice daily, depending on which group they are in. Some participants will take the medication alone, while others will combine it with one or more other cancer drugs. Throughout the study, you will have regular visits with the research team for blood tests, scans, and checkups to monitor how well the treatment is working and what side effects, if any, you experience.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States